Literature DB >> 8610527

Physicochemical properties of iodixanol.

K Eivindvik1, C E Sjogren.   

Abstract

Iodixanol, the radiopaque in Visipaque, is a new nonionic, dimeric roentgen contrast medium for intravascualr use. Compared to aqueous solutions of nonionic monomers, which have higher osmolality than blood, aqueous solutions of iodixanol have a lower osmolality due to dimeric structure of the molecule. As a consequence of this advantageous property, solutions of all clinical concentrations of iodixanol can be made isotonic by the addition of salts of the key electrolytes sodium and calcium to the formulation. The viscosity of all iodixanol (Visipaque) solutions is less than or equal to that of iohexol (Omnipaque) 350 mg I/ml. Iodixanol itself is an amorphorus and hygroscopic solid which is freely soluble in water. Partition coefficients show that iodixanol is even more hydrophilic than the nonionic monomers such as iohexol. The high hydrophilicity and the good aqueous solubility of iodixanol are due to the hydroxyl group in the dimer linkage and the hydrophilic amide side chains of the molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8610527     DOI: 10.1177/0284185195036s39904

Source DB:  PubMed          Journal:  Acta Radiol Suppl        ISSN: 0365-5954


  3 in total

1.  Intestinal permeability of x-ray constrast media iodixanol and iohexol during bacterial overgrowth of small intestines in rats.

Authors:  R Andersen; A Stordahl; S Aase; F Laerum
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Ionic mechanisms contributing to the vasorelaxant properties of iodinated contrast media: a comparison of iohexol and iodixanol in the rabbit isolated aorta.

Authors:  M R Pitman; J O Karlsson; T M Griffith
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

3.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.